Holen Sie sich die Stockscreener-App
84.46
1.20%
-1.03
Handel nachbörslich:
84.48
0.02
+0.02%
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
Oruka Therapeutics, Inc. (ORKA) stock price, news, quote and history - Yahoo Finance UK
Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says - Yahoo Finance
Oruka Therapeutics, Inc. (ORKA) Stock Price, News, Quote & History - Yahoo! Finance Canada
ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data - Yahoo Finance
Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright - Investing.com Canada
Oruka Therapeutics stock falls despite positive trial data - Investing.com
Clear Street Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $131 - Moomoo
What Oruka Therapeutics (ORKA)'s Phase 2a Psoriasis Data Means For Shareholders - Yahoo Finance
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001 - marketscreener.com
Update: Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001 - Yahoo Finance
10 Health Care Stocks Whale Activity In Today’s Session - Benzinga
Oruka posts trial data for plaque psoriasis drug (ORKA:NASDAQ) - Seeking Alpha
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy - AOL.com
Why is Oruka Therapeutics stock sliding today? By Investing.com - Investing.com Canada
Oruka Therapeutics Reports Deepening Responses for ORKA-001 Through Week 28 - marketscreener.com
Oruka Therapeutics Shares Fall 5% After Week 28 ORKA-001 Trial Data - Yahoo Finance
Oruka Therapeutics stock falls despite positive trial data By Investing.com - Investing.com Australia
Oruka reports week 28 psoriasis trial results for ORKA-001 By Investing.com - Investing.com Canada
In a psoriasis trial, 71% had clear skin six months after their last dose - stocktitan.net
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - ng.investing.com
Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada
Form 4 Oruka Therapeutics Inc For: 22 September - Investing.com UK
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com Australia
Details on Warrant Exercise and Subsequent Share Sales by Oruka Therapeutics' General Counsel - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal Sells 533 Shares Under Rule 10b5-1 Plan - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock - Investing.com UK
Oruka Therapeutics Insider Sold Shares Worth $936,417, According to a Recent SEC Filing - marketscreener.com
Oruka Therapeutics (NASDAQ: ORKA) insider plans new share sale after recent 10b5-1 trades - stocktitan.net
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 58.6% Potential Upside Beckons Biotech Investors - DirectorsTalk Interviews
LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $175 - Moomoo
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033 - PR Newswire
Oruka Therapeutics COO Sandler sells $86,713 in common stock By Investing.com - Investing.com South Africa
Oruka Therapeutics chief medical officer Joana Goncalves sells $734k in shares By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Agarwal sells over $926k in common stock By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Agarwal sells over $926k in common stock - Investing.com Canada
Oruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock - Investing.com
Oruka Therapeutics chief medical officer Joana Goncalves sells $734k in shares - Investing.com UK
Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock - Investing.com UK
Oruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com
Oruka Therapeutics CEO Lawrence Klein Executes 2,452-Share Sale for RSU Tax Withholding - Kalkine Media
Oruka Therapeutics SVP Finance Arjun Agarwal Reports Multiple Stock Option Exercises and Sales - Kalkine Media
Oruka Therapeutics to Attend Morgan Stanley Global Healthcare Conference - Bitget
Morgan Stanley's New York healthcare conference includes Oruka - Stock Titan
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference - GlobeNewswire
About Oruka Therapeutics Inc aStock - Coinbase
ORKA News | ORUKA THERAPEUTICS INC (NASDAQ:ORKA) - ChartMill
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy - Investing.com UK
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics(ORKA.US) Officer Sells US$6.89 Million in Common Stock - Moomoo
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):